Iantrek has filed a notice of an exempt offering of securities to raise $41,986,763.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Iantrek is raising up to $41,986,763.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Iantrek
Bio-interventional surgery. Iantrek is redefining what’s possible in micro-interventional ophthalmic surgery. We’re advancing next-generation technologies to transform total-outflow enhancement. Engineered for real-world intervention, our commercialized solutions can help you meet your surgical goals and make a difference in glaucoma patients’ lives. We deliver products of the highest quality on a consistent basis with unmatched customer service – all with the goal of meeting and exceeding customer expectations. Our engineers and designers at Inteplast have developed a vast collection of high performance building materials – from contemporary to classic – that keep homes, offices, and customized spaces looking beautiful for many years.
To learn more about Iantrek, visit https://iantrekmed.com/
Iantrek Linkedin Page: https://www.linkedin.com/company/iantrek-inc/
Contact:
Michael Haydin, Chief Financial Officer
914-708-6540
SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.
